Three-dimensional (3D) embedded printing is emerging
as a potential
solution for the fabrication of complex biological structures and
with ultrasoft biomaterials. For the supporting medium, bulk gels
can support a wide range of bioinks with higher printing resolution
as well as better finishing surfaces than granular microgel baths.
However, the difficulties of regulating the physical properties of
existing bulk gel supporting baths limit the further development of
this method. This work has developed a bulk gel supporting bath with
easily regulable physical properties to facilitate soft-material fabrication.
The proposed bath is composed based on the hydrophobic association
between a hydrophobically modified hydroxypropylmethyl cellulose (H-HPMC)
and Pluronic F-127 (PF-127). Its rheological properties can be easily
regulated; in the preprinting stage by varying the relative concentration
of components, during printing by changing the temperature, and postprinting
by adding additives with strong hydrophobicity or hydrophilicity.
This has made the supporting bath not only available for various bioinks
with a range of printing windows but also easy to be removed. Also,
the removal strategy is independent of printing conditions like temperature
and ions, which empowers the bath to hold great potential for the
embedded printing of commonly used biomaterials. The adjustable rheological
properties of the bath were leveraged to characterize the embedded
printing quantitatively, involving the disturbance during the printing,
filament cross-sectional shape, printing resolution, continuity, and
the coalescence between adjacent filaments. The match between the
bioink and the bath was also explored. Furthermore, low-viscosity
bioinks (with 0.008–2.4 Pa s viscosity) were patterned into
various 3D complex delicate soft structures (with a 0.5–5 kPa
compressive modulus). It is believed that such an easily regulable
assembled bath could serve as an available tool to support the complex
biological structure fabrication and open unique prospects for personalized
medicine.